# Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

Study · id `cardio:ct-nct03602742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03602742](<https://clinicaltrials.gov/study/NCT03602742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03602742

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT03602742. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-03-16 (actual); primary completion 2018-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT03602742, source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)
- Started: 2018-03-16 (actual) (ClinicalTrials.gov record NCT03602742, source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)
- Primary completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03602742, source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)
- Completion: 2018-12-31 (anticipated) (ClinicalTrials.gov record NCT03602742, source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT03602742, source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03602742-2018-07-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
- Condition: Atrial Fibrillation
- Condition: Arrhythmias, Cardiac
- Intervention (Device): EZYPRO®
- Lead sponsor: Sigknow Biomedical Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: a704662dec18029dc851c1536ccda922a081bf9f92e9de0a2b07e438d52f4164
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
